![Christopher Wright](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Christopher Wright
Technik-/Wissenschafts-/F&E-Leiter bei
WAVE LIFE SCIENCES, INC.
Vermögen: 2 Mio $ am 31.07.2026
Profil
Christopher I.
Wright is currently an Independent Director at Alkermes Plc since 2022.
Dr. Wright is also the Chief Medical Officer at Ring Therapeutics, Inc. since 2023 and at Wave Life Sciences Ltd. starting in 2025.
Former roles include SVP-Global Medicines Development & Medical Affairs at Vertex Pharmaceuticals, Inc., Associate Professor at Harvard Medical School, Chief Medical Officer & Senior Vice President at Axcella Health, Inc., Chief Development Officer & SVP-Global Development at Ironwood Pharmaceuticals, Inc. from 2017 to 2019, Chief Medical Officer & Senior Vice President at Cyclerion Therapeutics, Inc. from 2019 to 2021, and Chief Medical Officer & Senior Vice President at AavantiBio, Inc. from 2021 to 2022.
Education includes undergraduate studies at Harvard University, a doctorate from Vrije Universiteit Amsterdam, and graduate and doctorate degrees from Harvard Medical School.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 12.06.2026 | 25’680 ( 0.02% ) | 1 Mio $ | 31.07.2026 | |
| 09.04.2026 | 45’625 ( 0.02% ) | 251 394 $ | 31.07.2026 |
Aktive Positionen von Christopher Wright
| Unternehmen | Position | Beginn |
|---|---|---|
| ALKERMES PLC | Direktor/Vorstandsmitglied | 24.05.2022 |
| WAVE LIFE SCIENCES, INC. | Technik-/Wissenschafts-/F&E-Leiter | 28.05.2025 |
Ring Therapeutics, Inc.
 Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Technik-/Wissenschafts-/F&E-Leiter | 01.02.2023 |
Ehemalige bekannte Positionen von Christopher Wright
| Unternehmen | Position | Ende |
|---|---|---|
Aavantibio, Inc.
 Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2022 |
| CYCLERION THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | 26.03.2021 |
| IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01.04.2019 |
Harvard Medical School
 Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| AXCA HEALPAR | Technik-/Wissenschafts-/F&E-Leiter | - |
Ausbildung von Christopher Wright
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
54
Beziehungen ersten Grades
11
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 11 |
|---|---|
Vertex Pharmaceuticals, Inc.
 Vertex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a pharmaceutical company that develops drugs for the treatment of cystic fibrosis | Health Technology |
Ironwood Pharmaceuticals, Inc.
 Ironwood Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops, manufactures and markets gastrointestinal products | Health Technology |
Wave Life Sciences Ltd.
 Wave Life Sciences Ltd. BiotechnologyHealth Technology Operates as a biotechnology company that develops RNA oligonucleotides medicines | Health Technology |
Harvard University
 Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Vrije Universiteit Amsterdam
 Vrije Universiteit Amsterdam Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Harvard Medical School
Harvard Medical School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Alkermes Plc
 Alkermes Plc Pharmaceuticals: MajorHealth Technology Manufactures and commercializes pharmaceutical products to treat neurodegenerative disorders and cancer | Health Technology |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Cyclerion Therapeutics, Inc.
 Cyclerion Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and distributes pharmaceutical products for serious and orphan diseases | Health Technology |
Ring Therapeutics, Inc.
Ring Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops transforming commensal viruses therapies | Health Technology |
Aavantibio, Inc.
Aavantibio, Inc. BiotechnologyHealth Technology Operates as biotechnology company that develops new gene therapies | Health Technology |
